A Rapid Point-of-Care Test for Malaria Diagnostics in Elimination Settings
OPEN ACCESS
Author / Producer
Date
2018
Publication Type
Doctoral Thesis
ETH Bibliography
yes
Citations
Altmetric
OPEN ACCESS
Data
Rights / License
Abstract
One of the grand challenges in science and engineering today is the
development of innovative technologies to address global health concerns in
resource-limited settings. This thesis aims to develop self-driven microfluidicsbased
diagnostic tools suitable for detecting malaria at the point-of-care
(POC). In particular, the objective is to engineer devices that offer high
sensitivity, short turnover time, and are amendable to mass manufacturing.
In this thesis, we examine the current diagnostic needs for malaria elimination,
and identify gaps and opportunities in existing detection tools for malaria.
Next, we provide an overview of new malaria diagnostic technologies that
could be suitable for low resource settings. We also examine how innovative
technologies such as microfluidics can assist in the global defeat of this
ancient scourge. Specific examples are also discussed to illustrate the
potential of advancement in technology in compliance to simplicity of use,
appropriateness and affordability.
We develop microfluidics-based proof-of-concept diagnostic devices that are
based on the understanding of an ideal malaria rapid test for the elimination
context. Two key challenges are addressed, 1) the improvement of sensitivity,
and 2) the integration of an immunodiagnostic assay into a self-driven
microfluidics platform. To solve the first challenge, we use immuno-gold
silver-staining (IGSS) as a mean to strongly amplify signal intensity. The
growth of silver film over time for a model immunoassay is characterized and
the optimum development time is in agreement with the literature. Additionally,
we also confirm the stability of the assay using IGSS at 24°C and 37 °C.
To solve the 2nd challenge, we integrate a number of microfluidic elements on
the chip. A highlight of this proof-of-concept is the elegant implementation of
fluorescent microbeads that serves a two-fold purpose. First, the beads
provide sufficient surface to immobilize capture antibodies (cAbs). Second, as
the target analyte is captured, silver is produced and this silver film masks the
fluorescence emitted from the core of the beads. The detection method for
the device therefore relies on fluorescence attenuation and the analyte
concentration being inversely proportional. The integrated, capillary-driven
microfluidic chip can accommodate 700 nanoliter of liquids and take 20
minutes to detect 17.1 ng mL-1 rabbit IgG, compared to milliliters of liquids
and hours needed to detect 24.6 ng mL-1 rabbit IgG using a standard enzymelinked
immunosorbent assay (ELISA) on microtiter plates.
The proof-of-concept is further extended to detect the presence of
Plasmodium falciparum histidine-rich protein-2 (PfHR2) in human serum.
Amongst various types of malaria Plasmodium infections, Plasmodium
falciparum (Pf) infection is the most fatal one. Symptoms associated with Pf
infections are often misinterpreted with other febrile fevers, which results in
available treatments not being administered in time. Therefore, the ability to
detect the presence of PfHRP2 at the onset of infection is key. Current
malaria rapid tests cannot detect low PfHRP2 concentrations (6 ngmL-1), with
the exception of nucleic amplification technologies. We base our work on the
same chip design and fabrication procedure as before. Unlike the previous
assay developed for rabbit IgG, we further improve the sensitivity of the
PfHRP2 detection immunoassay by using secondary antibodies to amplify
signal intensity before applying the IGSS technique. Since the core of the
microbeads is fluorescent, photobleaching and stability issues often found in
fluorescent assays are mitigated. The self-driven microfluidic chip is capable
of achieving a limit of detection of less than 6 ng mL-1 PfHRP2 in human
serum within 20 minutes. This limit of detection surpasses the requirement
needed for the ideal malaria diagnostic tests for the elimination context set
out by the Foundation for Innovative New Diagnostics (FIND).
Looking towards the future, such chips, especially if manufactured in low cost
plastic and used in combination with smartphone-based fluorescence readers,
have the potential to drive the widespread adoption of fluorescent bead-based
immunoassays using capillary-driven microfluidics for POC diagnostics
applications.
Permanent link
Publication status
published
External links
Editor
Contributors
Book title
Journal / series
Volume
Pages / Article No.
Publisher
ETH Zurich
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
malaria; elimination; Plasmodium falciparum histidine-rich protein- 2; fluorescent; microbeads; silver staining; immunoassay; microfluidics; rapid diagnostic tests
Organisational unit
09533 - Karlen, Walter (ehemalig) / Karlen, Walter (former)